Marshall Wace’s CoLucid Pharmaceuticals, Inc. CLCD Stock Holding History

Marshall Wace’s Portfolio CLCD Stock Details CLCD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-485,824	Closed	-$17.7M	–	969
2016 Q4	$17.7M	Buy	485,824 +306,344	+171%	+$10.8M	0.12%	213
2016 Q3	$6.85M	Buy	+179,480	New	+$2.65M	0.05%	342

Other funds holding CLCD

FPF

FNY Partners Fund New York $185M AUM 32.57% 1-Year Est. Return

Marshall Wace's CLCD Position: Q1 2017 in Review

Marshall Wace sold out of CoLucid Pharmaceuticals, Inc. (CLCD) in Q1 2017, closing a stake of 485,824 shares — an estimated $17.7M sold.

Marshall Wace first reported a position in CLCD in Q3 2016 and held it in 2 quarters. The position peaked at $17.7M in Q4 2016. 1 fund tracked by Wall St. Rank holds CLCD as of Q1 2017.

Marshall Wace reported no remaining CoLucid Pharmaceuticals, Inc. position as of Q1 2017 after selling out during the quarter.
Marshall Wace sold 485,824 CoLucid Pharmaceuticals, Inc. shares in Q1 2017, an estimated $17.7M.
Marshall Wace first reported a position in CoLucid Pharmaceuticals, Inc. in Q3 2016 and held it in 2 quarters.
Marshall Wace's CoLucid Pharmaceuticals, Inc. position peaked at $17.7M in Q4 2016.
1 fund tracked by Wall St. Rank held CoLucid Pharmaceuticals, Inc. as of Q1 2017.

Based on Marshall Wace's 13F filing for Q1 2017, filed 12 May 2017.